ProKidney (PROK)
NASDAQ:PROK
US Market

ProKidney (PROK) Stock Price & Analysis

19 Followers

PROK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.14 - $14.00
Previous Close$11
Volume42.22K
Average Volume (3M)111.53K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$51.89K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-24.2
Beta0.74
Next EarningsNov 14, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-0.45
Shares Outstanding61,540,231
R-Squared0.14
Standard Deviation0.14
10 Day Avg. Volume78,541
30 Day Avg. Volume111,534
Price to Book (P/B)-0.59
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-10.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside32.64% Upside
Rating ConsensusModerate Buy
Alpha0.01
Number of Analyst Covering2


Financials

Annual

PROK FAQ

What was ProKidney’s price range in the past 12 months?
ProKidney lowest stock price was $5.14 and its highest was $14.00 in the past 12 months.
    What is ProKidney’s market cap?
    Currently, no data Available
    When is ProKidney’s upcoming earnings report date?
    ProKidney’s upcoming earnings report date is Nov 14, 2022 which is 85 days ago.
      How were ProKidney’s earnings last quarter?
      ProKidney released its earnings results on Aug 11, 2022. The company reported -$0.036 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.036.
        Is ProKidney overvalued?
        According to Wall Street analysts ProKidney’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does ProKidney pay dividends?
          ProKidney does not currently pay dividends.
          What is ProKidney’s EPS estimate?
          ProKidney’s EPS estimate is -$0.24.
            How many shares outstanding does ProKidney have?
            ProKidney has 61,540,230 shares outstanding.
              What happened to ProKidney’s price movement after its last earnings report?
              ProKidney reported an EPS of -$0.036 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.582%.
                Which hedge fund is a major shareholder of ProKidney?
                Among the largest hedge funds holding ProKidney’s share is Moore Capital Management LP. It holds ProKidney’s shares valued at 239K.

                  ---

                  ProKidney Stock Smart Score

                  4
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  11.56%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  Trailing 12-Months
                  Asset Growth
                  111.75%
                  Trailing 12-Months
                  The ProKidney stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  ProKidney

                  Social Capital Suvretta Holdings Corp III is a blank check company.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  BioCryst
                  Arcus Biosciences
                  Relay Therapeutics
                  Akero Therapeutics
                  SAGE Therapeutics

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis